Could a 3-day antibiotic course cure chlamydia just as well as 7 days?
NCT ID NCT05840159
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 34 times
Summary
This study tested whether taking doxycycline for 3 days works as well as the standard 7-day course to cure chlamydia. About 664 men and women with chlamydia took either a 3-day or 7-day regimen, and were tested again after 28 days. The goal is to see if a shorter treatment can be just as effective, making it easier for patients to complete.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHLAMYDIAL INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emory University Hospital Midtown - Emory Clinic Infectious Diseases
Atlanta, Georgia, 30308, United States
-
Grady Memorial Hospital
Atlanta, Georgia, 30303, United States
-
KEMRI-CCR PHRD Project
Thika, Kenya
-
Pwani Research Centre
Mombasa, Kenya
-
University of Alabama at Birmingham School of Medicine - Infectious Disease
Birmingham, Alabama, 35222, United States
-
University of Rochester Medical Center - Vaccine Research Unit
Rochester, New York, 14642-0001, United States
-
University of Washington - Harborview Medical Center - Center for AIDS and STD
Seattle, Washington, 98104-2433, United States
Conditions
Explore the condition pages connected to this study.